Graded Exposure Therapy for Concussion
This trial will assess whether graded exposure therapy is effective in reducing fear avoidance behavior in people with concussion.
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
How many individuals are participating in this research protocol?
"This medical trial needs 220 eligible patients to join. They can register at the Sunnybrooke Traumatic Brain Injury Clinic in Langley, BC or with Fraser Health Acquired Brain Injury and Concussion Services in Calgary, AB."
Is it possible to enlist in this clinical research?
"For this trial, 220 individuals aged 18-69 who have sustained a traumatic brain injury in the past 12 months must be enrolled. Selected patients should also possess fluency in English, access to internet enabled technology and present with 3 or more moderate-severe symptoms on the Rivermead Postconcussion Symptom Questionnaire."
What is the current count of participating healthcare facilities in this experiment?
"Currently, 6 different medical centres are enrolling participants in this trial. This includes sites based in Langley, Calgary and Vancouver; among other locales. Selecting the facility nearest you is suggested to reduce any commuting challenges for patients who decide to take part."
Are applications being accepted for participation in this clinical experiment?
"The details found on clinicaltrials.gov suggest that the trial is still recruiting participants, with initial postings made in early June 2022 and recent updates provided at the beginning of August."
Is this experimental program recruiting participants over 40 years of age?
"The lower limit for eligibility in this clinical trial is 18 years old and the upper cutoff age is 69."